American Journal of Cardiology
Volume 104, Issue 11 , Pages 1472-1477 , 1 December 2009

Relation of Cardiac Troponin I Measurements at 24 and 48 Hours to Magnetic Resonance–Determined Infarct Size in Patients With ST-Elevation Myocardial Infarction

  • Jonas Hallén, MD

      Affiliations

    • Division of Cardiology, Oslo University Hospital, Aker, Oslo, Norway
    • Faculty of Medicine, University of Oslo, Oslo, Norway
    • Corresponding Author InformationCorresponding author: Tel: 47-2303-4572; fax: 47-2154-7325
    • ,
  • Peter Buser, MD, PhD

      Affiliations

    • Department of Cardiology, University Hospital, Basel, Basel, Switzerland
    • ,
  • Jürg Schwitter, MD

      Affiliations

    • Division of Cardiology, University Hospital of Canton de Vaud (CHUV), Lausanne, Switzerland
    • ,
  • Peter Petzelbauer, MD, PhD

      Affiliations

    • Medical University of Vienna, Vienna, Austria
    • ,
  • Bernard Geudelin, MD

      Affiliations

    • Fibrex Medical Research and Development, GmbH, Vienna, Austria
    • ,
  • Morten W. Fagerland, MSc

      Affiliations

    • Department of Research Administration, Oslo University Hospital, Ullevål, Oslo, Norway
    • ,
  • Allan S. Jaffe, MD

      Affiliations

    • Division of Cardiovascular Diseases, Department of Medicine, and Department of Laboratory Medicine and Pathology, Mayo Clinic, Medical School, Rochester, Minnesota
    • ,
  • Dan Atar, MD

      Affiliations

    • Division of Cardiology, Oslo University Hospital, Aker, Oslo, Norway
    • Faculty of Medicine, University of Oslo, Oslo, Norway

Received 22 May 2009 ,Revised 10 July 2009 ,Accepted 10 July 2009.

References 

  1. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, et al. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol. 2009;53:720–729
  2. Atar D, Huber K, Rupprecht HJ, Kopecky SL, Schwitter J, Theek C, et al. Rationale and design of the 'F.I.R.E.' study (A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15–42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention). Cardiology. 2007;108:117–123
  3. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions (The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology). Eur Heart J. 2005;26:804–847
  4. Nijveldt R, Beek AM, Hofman MBM, Umans VAWM, Algra PR, Spreeuwenberg MD, et al. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction. J Cardiovasc Magn Reson. 2007;9:765–770
  5. Syed MA, Carlson K, Murphy M, Ingkanisorn WP, Rhoads KL, Arai AE. Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging. 2006;24:1056–1061
  6. Altman DG, Gardner MJ. Calculating confidence intervals for regression and correlation. Br Med J Clin Res Ed. 1988;296:1238–1242
  7. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94:730–736
  8. Panteghini M, Bonetti G, Pagani F, Stefini F, Giubbini R, Cuccia C. Measurement of troponin I 48 h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction. Clin Chem Lab Med. 2005;43:848–854
  9. Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol. 2006;48:2192–2194
  10. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, et al. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol. 2008;51:307–314
  11. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart. 2002;87:520–524
  12. Mair J, Wagner I, Morass B, Fridrich L, Lechleitner P, Dienstl F, et al. Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem. 1995;33:869–872
  13. Wagner I, Mair J, Fridrich L, Artner-Dworzak E, Lechleitner P, Morass B, et al. Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Coron Artery Dis. 1993;4:537–544
  14. Tanaka H, Abe S, Yamashita T, Arima S, Saigo M, Nakao S, et al. Serum levels of cardiac troponin I and troponin T in estimating myocardial infarct size soon after reperfusion. Coron Artery Dis. 1997;8:433–439
  15. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008;1:415–423
  16. Vasile VC, Babuin L, Giannitsis E, Katus HA, Jaffe AS. Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction. Clin Chem. 2008;54:617–619
  17. Bohmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S. Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months. Cardiology. 2009;113:207–212
  18. Younger JF, Plein S, Barth J, Ridgway JP, Ball SG, Greenwood JP. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart. 2007;93:1547–1551
  19. Baks T, van Geuns RJ, Biagini E, Wielopolski P, Mollet NR, Cademartiri F, et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol. 2006;47:40–44

 Dr. Hallén was supported by grants from the South-Eastern Norway Regional Health Authority, Aker University Hospital Research Foundation, and Center for Heart Failure Research, Oslo, Norway.

PII: S0002-9149(09)01356-3

doi: 10.1016/j.amjcard.2009.07.019

American Journal of Cardiology
Volume 104, Issue 11 , Pages 1472-1477 , 1 December 2009

Article Tools

* Image Usage & Resolution